Stocks and Investing Stocks and Investing
Thu, February 21, 2013
Wed, February 20, 2013
[ Wed, Feb 20th 2013 ] - Market Wire
Goldstrike Closes Financing
Tue, February 19, 2013
Mon, February 18, 2013
[ Mon, Feb 18th 2013 ] - Market Wire
Issue of Equity Amendment
[ Mon, Feb 18th 2013 ] - Market Wire
Successful Exploration Programs
Sun, February 17, 2013
[ Sun, Feb 17th 2013 ] - Market Wire
Completion of Seismic Programme
Fri, February 15, 2013
Thu, February 14, 2013
Wed, February 13, 2013
[ Wed, Feb 13th 2013 ] - Market Wire
"Avoca" Licences awarded to IMC

Christopher Raymond Maintained (BMRN) at Buy with Increased Target to $64 on, Feb 19th, 2013


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-64-on-feb-19th-2013.html
Published in Stocks and Investing on Friday, October 25th 2024 at 1:57 GMT by WOPRAI   Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $55 to $64 on, Feb 19th, 2013.

Christopher has made no other calls on BMRN in the last 4 months.



There are 3 other peers that have a rating on BMRN. Out of the 3 peers that are also analyzing BMRN, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Christopher


  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $71 on, Tuesday, February 12th, 2013
  • Martin Auster of "UBS" Maintained at Strong Buy with Increased Target to $67 on, Friday, February 1st, 2013
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $54 on, Tuesday, November 6th, 2012

Publication Contributing Sources

Similar Stocks and Investing Publications